|
| 36328830 | Utilization of Non-Drug-Eluting Devices for Inpatient Percutaneous Coronary Intervention in the United States. | Am J Cardiol | 2023 |
| 37558240 | Long term risk of death and readmission after hospital admission with covid-19 among older adults: retrospective cohort study. | BMJ | 2023 |
| 37621213 | Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants. | Circulation | 2023 |
| 37549203 | Bringing the Credibility Revolution to Observational Research in Cardiology. | Circulation | 2023 |
| 37610768 | Deferred Testing in Stable Outpatients With Suspected Coronary Artery Disease: A Prespecified Secondary Analysis of the PRECISE Randomized Clinical Trial. | JAMA Cardiol | 2023 |
| 37610731 | Comparison of an Initial Risk-Based Testing Strategy vs Usual Testing in Stable Symptomatic Patients With Suspected Coronary Artery Disease: The PRECISE Randomized Clinical Trial. | JAMA Cardiol | 2023 |
| 37778226 | Bleeding and Ischemic Risk Prediction in Patients With High Bleeding Risk (an EVOLVE Short DAPT Analysis). | Am J Cardiol | 2023 |
| 37676058 | Percutaneous ventricular assist device for higher-risk percutaneous coronary intervention in surgically ineligible patients: Indications and outcomes from the OPTIMUM study. | Catheter Cardiovasc Interv | 2023 |
| 37532425 | Bridging Treatment Implementation Gaps in Patients With Heart Failure: JACC Focus Seminar 2/3. | J Am Coll Cardiol | 2023 |
| 35680547 | Assessment of the Social Security Administration Death Master File for Comparative Analysis Studies of Peripheral Vascular Devices. | Value Health | 2023 |
| 37158994 | Availability and Use of In-Person and Virtual Cardiac Rehabilitation Among US Medicare Beneficiaries: A Post-Pandemic Update. | J Cardiopulm Rehabil Prev | 2023 |
| 37083188 | Preoperative frailty and adverse outcomes following coronary artery bypass grafting surgery in US veterans. | J Am Geriatr Soc | 2023 |
| 37449567 | Association Between Claims-Defined Frailty and Outcomes Following 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND-DAPT Study. | J Am Heart Assoc | 2023 |
| 37045519 | Out-of-Pocket Drug Costs for Medicare Beneficiaries With Cardiovascular Risk Factors Under the Inflation Reduction Act. | J Am Coll Cardiol | 2023 |
| 37342056 | Comparative Effectiveness of Percutaneous Microaxial Left Ventricular Assist Device vs Intra-Aortic Balloon Pump or No Mechanical Circulatory Support in Patients With Cardiogenic Shock. | JAMA Cardiol | 2023 |
| 37042289 | Trends in Spending and Claims for P2Y12 Inhibitors by Medicare and Medicaid From 2015 to 2020. | J Am Heart Assoc | 2023 |
| 37074702 | Quality of Care and Clinical Outcomes for Patients With Heart Failure at Hospitals Caring for a High Proportion of Black Adults: Get With The Guidelines-Heart Failure Registry. | JAMA Cardiol | 2023 |
| 37335828 | Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium. | Circulation | 2023 |
| 37204378 | Incidence, Treatment, and Outcomes of Symptomatic Device Lead-Related Venous Obstruction. | J Am Coll Cardiol | 2023 |
| 37464975 | Intravascular imaging during percutaneous coronary intervention: temporal trends and clinical outcomes in the USA. | Eur Heart J | 2023 |
| 36789851 | Clinical Characteristics and Outcomes Among People Living With HIV Undergoing Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. | J Am Heart Assoc | 2023 |
| 36626181 | Quantitative Analyses of Regulatory Policies for Medical Devices: Matching the Methods to the Moment. | JAMA | 2023 |
| 36472193 | Association of Clinical Setting With Sociodemographics and Outcomes Following Endovascular Femoropopliteal Artery Revascularization in the United States. | Circ Cardiovasc Qual Outcomes | 2023 |
| 36512989 | Use of Mechanical Circulatory Support in Chronic Total Occlusion Percutaneous Coronary Intervention. | Am J Cardiol | 2023 |
| 36871237 | Cardiovascular Risk Factor Prevalence, Treatment, and Control in US Adults Aged 20 to 44 Years, 2009 to March 2020. | JAMA | 2023 |
| 36866664 | Comparison of Unibody and Non-Unibody Endografts for Abdominal Aortic Aneurysm Repair in Medicare Beneficiaries: The SAFE-AAA Study. | Circulation | 2023 |
| 36530151 | Comparative performance of distinct frailty measures among patients undergoing percutaneous left atrial appendage closure. | Pacing Clin Electrophysiol | 2023 |
| 36792252 | Outcomes of Medical Therapy Plus PCI for Multivessel or Left Main CAD Ineligible for Surgery. | JACC Cardiovasc Interv | 2023 |
| 36309128 | Days at home after transcatheter or surgical aortic valve replacement in high-risk patients. | Am Heart J | 2023 |
| 34505979 | Neighborhood Socioeconomic Disadvantage and Mortality Among Medicare Beneficiaries Hospitalized for Acute Myocardial Infarction, Heart Failure, and Pneumonia. | J Gen Intern Med | 2022 |
| 35574949 | Predicting Residual Angina After Chronic Total Occlusion Percutaneous Coronary Intervention: Insights from the OPEN-CTO Registry. | J Am Heart Assoc | 2022 |
| 35533384 | Diabetes Screening by Race and Ethnicity in the United States: Equivalent Body Mass Index and Age Thresholds. | Ann Intern Med | 2022 |
| 35695005 | Differences in Comorbidities Explain Black-White Disparities in Outcomes After Femoropopliteal Endovascular Intervention. | Circulation | 2022 |
| 35862003 | County-Level Social Vulnerability is Associated With In-Hospital Death and Major Adverse Cardiovascular Events in Patients Hospitalized With COVID-19: An Analysis of the American Heart Association COVID-19 Cardiovascular Disease Registry. | Circ Cardiovasc Qual Outcomes | 2022 |
| 35861764 | Disparities in Cardiovascular Mortality Between Black and White Adults in the United States, 1999 to 2019. | Circulation | 2022 |
| 35361344 | Outcomes Associated With Peripheral Artery Disease in Myocardial Infarction With Cardiogenic Shock. | J Am Coll Cardiol | 2022 |
| 35593638 | Update From the Longitudinal Assessment of Safety of Femoropopliteal Endovascular Treatment With Paclitaxel-Coated Devices Among Medicare Beneficiaries: The SAFE-PAD Study. | Circ Cardiovasc Interv | 2022 |
| 35849412 | Assessment of Prices for Cardiovascular Tests and Procedures at Top-Ranked US Hospitals. | JAMA Intern Med | 2022 |
| 36001332 | The Need to Standardize Our Language Around Dual Antiplatelet Therapy-A Call to Action. | JAMA Cardiol | 2022 |
| 36041194 | Spending on Insulin by U.S. Payers and Patients From 2008 to 2017. | Diabetes Care | 2022 |
| 36335507 | Time to Treatment in ST-Segment Elevation Myocardial Infarction: Identifying Dangerous Delays or Diminishing Returns? | JAMA | 2022 |
| 35997731 | Trends in Lipid Concentrations and Lipid Control Among US Adults, 2007-2018. | JAMA | 2022 |
| 35904016 | Rising Use of Percutaneous Ventricular Assist Devices: What Can Be Learned From the Data? | Circ Cardiovasc Interv | 2022 |
| 36102226 | Enriching the American Heart Association COVID-19 Cardiovascular Disease Registry Through Linkage With External Data Sources: Rationale and Design. | J Am Heart Assoc | 2022 |
| 36065983 | In-hospital outcomes and temporal trends of percutaneous coronary interventions for chronic total occlusion. | EuroIntervention | 2022 |
| 35863789 | Predicting Periprocedural Complications in Chronic Total Occlusion Percutaneous Coronary Intervention: The PROGRESS-CTO Complication Scores. | JACC Cardiovasc Interv | 2022 |
| 36302587 | Ischemic Risk Prediction Scores: Practice-Changing or Just Practice? | J Am Coll Cardiol | 2022 |
| 36029191 | Characterizing the Accuracy of <i>International Classification of Diseases, Tenth Revision</i> Administrative Claims for Aortic Valve Disease. | Circ Cardiovasc Qual Outcomes | 2022 |
| 36194574 | Medicare eligibility and healthcare access, affordability, and financial strain for low- and higher-income adults in the United States: A regression discontinuity analysis. | PLoS Med | 2022 |
| 36052688 | Association Between Medicare Program Type and Health Care Access, Acute Care Utilization, and Affordability Among Adults With Cardiovascular Disease. | Circ Cardiovasc Qual Outcomes | 2022 |